Efficacy of afatinib or osimertinib plus cetuximab combination therapy for non-small-cell lung cancer with EGFR exon 20 insertion mutations
Keyword(s):
Exon 20
◽
2019 ◽
Vol 14
(9)
◽
pp. e201-e202
◽
Keyword(s):